Yune Zhao
11
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
18.2%
2 terminated/withdrawn out of 11 trials
60.0%
-26.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation
Role: lead
Morphological Changes of Ciliary Body and Trabecular Meshwork
Role: lead
Improved Operation of Low Intraocular Pressure in Phacoemulsification for Patients With High Myopia Complicated With Cataract
Role: lead
To Compare the Progressive Cracking Technique and Conventional Chop Technique on Corneal Endothelial Cells in Patients With Hard Nucleus Cataract
Role: lead
Reduced ER-QOL in Families After Congenital Cataract Surgery
Role: lead
Capsular Outcomes of Pediatric Cataract Surgery With Primary Intraocular Lens Implantation
Role: lead
Effect of Cataract Hyperemulsification Surgery on Meibomian Gland Morphology and Function
Role: lead
Effect of Meibomian Gland Related Therapy on the Morphology of Meibomian Gland
Role: lead
Age-related Changes of Crystalline Lens Tilt and Decentration: A Swept-source Optical Coherence Tomography Study
Role: lead
Assessment Of Anterior Chamber Configuration Changes After Phacoemulsification With Swept-Source Optical Coherence Tomography
Role: lead
Congenital Cataract With Persistent Fetal Vasculature
Role: lead
All 11 trials loaded